Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Molecular Therapy. Methods & Clinical Development|March 24, 2020
Optimized Assessment of qPCR-Based Vector Copy Numbers as a Safety Parameter for GMP-Grade CAR T Cells and Monitoring of Frequency in PatientsAlexander Kunz, Ulrike Gern, Anita Schmitt, et al.
Cancers|October 3, 2020
Assessment of CAR T Cell Frequencies in Axicabtagene Ciloleucel and Tisagenlecleucel Patients Using Duplex Quantitative PCRMaria-Luisa Schubert, Alexander Kunz, Anita Schmitt, et al.
Human Gene Therapy|July 20, 2018
Influence of Retronectin-Mediated T-Cell Activation on Expansion and Phenotype of CD19-Specific Chimeric Antigen Receptor T CellsSophia Stock, Jean-Marc Hoffmann, Maria-Luisa Schubert, et al.
Cells|November 27, 2021
Sensitivity and Specificity of CD19.CAR-T Cell Detection by Flow Cytometry and PCRNicola Schanda, Tim Sauer, Alexander Kunz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2020
Feasibility and Safety of CD19 Chimeric Antigen Receptor T Cell Treatment for B Cell Lymphoma Relapse after Allogeneic Hematopoietic Stem Cell TransplantationMaria-Luisa Schubert, Sascha Dietrich, Stephan Stilgenbauer, et al.
Biomedicines|February 25, 2022
HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-Positive Soft Tissue SarcomaWenjie Gong, Lei Wang, Maria-Luisa Schubert, et al.
Cells|January 20, 2021
Evaluation of Production Protocols for the Generation of NY-ESO-1-Specific T CellsWenjie Gong, Lei Wang, Sophia Stock, et al.
Cancer Immunology, Immunotherapy : CII|June 10, 2019
Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cellsWenjie Gong, Jean-Marc Hoffmann, Sophia Stock, et al.
Pageof 5